Dr. Reddy's Laboratories Ltd. Sponsored ADR Stock News

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)---- $RDY #Bridion--Dr. Reddy's Laboratories today announced launch of Sugammadex Injection of Single-Dose Vials, a generic equivalent of Bridion®, in the United States.

U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing of generic drugs in India leads to a significant decrease in the cost of medicine to the United States.

Indian drugmaker Dr ​Reddy's reported a ‌smaller-than-expected quarterly profit on Wednesday, as ​muted sales ​of a key generic ⁠oncology drug ​and pricing pressure ​weighed on the competitive U.S. market.

Torrent Pharmaceuticals ​said ‌on Thursday it ​was ​voluntarily recalling ⁠select ​batches ​of its Semalix semaglutide ​injection ​disposable pens ‌after ⁠a product recall notification ​from ​its ⁠manufacturer ​Dr. ​Reddy's ⁠Laboratories.

HYDERABAD, India--(BUSINESS WIRE)---- $RDY #AmericanDepositaryReceipts--Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F.

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)---- $RDY #Bosulif--Dr. Reddy's Laboratories Ltd. announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif® in the United States.

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 29, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.